Fidaxomicin

Especificaciones

873857-62-6Número CAS

692-555-6Número CE

[(2R,3S,4S,5S,6R)-6-[[(3E,5E,8S,9E,11S,12R,13E,15E,18S)-12-[(2R,3S,4R,5S)-3,4-dihydroxy-6,6-dimethyl-5-(2-methylpropanoyloxy)oxan-2-yl]oxy-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-2-oxo-1-oxacyclooctadeca-3,5,9,13,15-pentaen-3-yl]methNombre IUPAC

C52H74Cl2O18Fórmula química

1058 g/molPeso molecular

Fidaxomicin; Tiacumicin B; 873857-62-6; Dificid; Dificlir; Lipiarmicin; OPT-80; Difimicin; PAR-101; fidaxomicine; Fidaxomicina; Lipiarmycin A3; Z5N076G8YQ; DTXSID901016415; OPT 80; PAR 101; [(2R,3S,4S,5S,6R)-6-[[(3E,5E,8S,9E,11S,12R,13E,15E,18S)-12-[(2R,3S,4R,5S)-3,4-dihydroxy-6,6-dimethyl-5-(2-methylpropanoyloxy)oxan-2-yl]oxy-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-2-oxo-1-oxacyclooctadeca-3,5,9,13,15-pentaen-3-yl]methoxy]-4-hydroxy-5-methoxy-2-methyloxan-3-yl] 3,5-dichloro-2-ethyl-4,6-dihydroxybenzoate; CHEBI:68590; fidaxomicinum; ((2R,3S,4S,5S,6R)-6-(((3E,5E,8S,9E,11S,12R,13E,15E,18S)-12-((2R,3S,4R,5S)-3,4-dihydroxy-6,6-dimethyl-5-(2-methylpropanoyloxy)oxan-2-yl)oxy-11-ethyl-8-hydroxy-18-((1R)-1-hydroxyethyl)-9,13,15-trimethyl-2-oxo-1-oxacyclooctadeca-3,5,9,13,15-pentaen-3-yl)methoxy)-4-hydroxy-5-methoxy-2-methyloxan-3-yl) 3,5-dichloro-2-ethyl-4,6-dihydroxybenzoate; OPT80 cpd; RefChem:57141; PAR101; A07AA12; DTXCID801474599; ((2R,3S,4S,5S,6R)-6-(((3E,5E,8S,9E,11S,12R,13E,15E)-12-((2R,3S,4R,5S)-3,4-dihydroxy-6,6-dimethyl-5-(2-methylpropanoyloxy)oxan-2-yl)oxy-11-ethyl-8-hydroxy-18-((1R)-1-hydroxyethyl)-9,13,15-trimethyl-2-oxo-1-oxacyclooctadeca-3,5,9,13,15-pentaen-3-yl)methoxy)-4-hydroxy-5-methoxy-2-methyloxan-3-yl) 3,5-dichloro-2-ethyl-4,6-dihydroxybenzoate; MFCD27976367; C52H74Cl2O18; Clostomicin B1; R-Tiacumicin B; Lipiarmycin A 3; (2R,3S,4S,5S,6R)-6-{[(3E,5E,8S,9E,11S,12R,13E,15E,18S)-12-{[(2R,3S,4R,5S)-3,4-dihydroxy-6,6-dimethyl-5-[(2-methylpropanoyl)oxy]oxan-2-yl]oxy}-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-2-oxo-1-oxacyclooctadeca-3,5,9,13,15-pentaen-3-yl]methoxy}-4-hydroxy-5-methoxy-2-methyloxan-3-yl 3,5-dichloro-2-ethyl-4,6-dihydroxybenzoate; Fidaxomicin [USAN]; Fidaxomicin [USAN:INN]; UNII-Z5N076G8YQ; Lipiarrmycin; PAR 01; Clostomycin B1; (2R,3S,4S,5S,6R)-6-({(3E,5E,8S,9E,11S,12R,13E,15E,18S)-12-({(2R,3S,4R,5S)-3,4-Dihydroxy-6,6-dimethyl-5-[(2-methylpropanoyl)oxy]oxan-2-yl}oxy)-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-2-oxo-1-oxacyclooctadeca-3,5,9,13,15-pentaen-3-yl}methoxy)-4-hydroxy-5-methoxy-2-methyloxan-3-yl 3,5-dichloro-2-ethyl-4,6-dihydroxybenzoate; Fidaxomicin (Dificid); BRN 5228707; Fidaxomicin Impurity 16; FIDAXOMICIN [MI]; FIDAXOMICIN [INN]; FIDAXOMICIN [JAN]; FIDAXOMICIN [VANDF]; FIDAXOMICIN [WHO-DD]; orb1223774; orb1300992; CHEMBL1255800; SCHEMBL10000818; SCHEMBL29360123; Fidaxomicin, >=98% (HPLC); GTPL10909; FIDAXOMICIN [ORANGE BOOK]; GLXC-90140; FI8; MSK169310; AKOS040758974; AF31015; DB08874; SY116019; F1216; T6194; OPT-80;PAR-101;Clostomicin B1;Tiacumicin B; EN300-21995976; F285081; Q5446672; Oxacyclooctadeca-3,5,9,13,15-pentaen-2-one, 3-[[[6-deoxy-4-O-(3,5-dichloro-2-ethyl-4,6-dihydroxybenzoyl)-2-O-methyl-beta-D-mannopyranosyl]oxy]methyl]-12-[[6-deoxy-5-C-methyl-4-O-(2-methyl-1-oxopropyl)-beta-D-lyxo-hexopyranosyl]oxy]-11-ethyl-8-hydroxy-18-[(1R)-1Sinónimos